万维书刊网微信二维码

扫微信,关注编辑QQ!

您的位置:万维书刊网 >>期刊大全 >>SCI/SCIE期刊 >>医药卫生>>内科学

Panminerva Medica(研究方向:内科) (官网投稿)

简介
Panminerva Medica(季刊),创刊于1959年,出版国家为意大利。杂志发表了关于内科学的科学论文。手稿可以以编辑,原创文章,评论文章,案例报告,特别文章和信件的形式提交给编辑。
本刊为:SCIE期刊(2015-2016), 外文期刊,
征稿信息

万维提示:

1、投稿方式:在线投稿。

2、期刊官网:

http://www.minervamedica.it/en/journals/panminerva-medica/

3、期刊投稿:

http://www.minervamedicaonlinesubmission.it/?CollectionSetId=37

4、信息说明:本刊信息来源于网络,包括 SCI 收录核心期刊,增补期刊,期刊收录数据每年进行更新。本站是公益性网站,为网友投稿提供免费服务,由于受相关约束,我们不能提供相关期刊的影响因子、JCR期刊分区等数据供大家参考,造成不便,敬请谅解。

2017428日星期五

                        

 

Author Guidelines

 

The journal Panminerva Medica publishes scientific papers on internal medicine. Manuscripts may be submitted in the form of editorials, original articles, review articles, case reports, special articles and letters to the Editor.

Manuscripts are expected to comply with the instructions to authors which conform to the Uniform Requirements for Manuscripts Submitted to Biomedical Editors by the International Committee of Medical Journal Editors (http://www.icmje.org).

Articles not conforming to international standards will not be considered for acceptance.

Submission of manuscripts

Papers should be submitted directly to the online Editorial Office at the Edizioni Minerva Medica website: http://www.minervamedicaonlinesubmission.it

Authors are requested to choose a corresponding author delegated to communicate with the journal during the manuscript submission, peer review and publication process. Although for technical and organizational reasons the corresponding author has primary responsibility for correspondence with the journal, copies of the most significant correspondence will be sent to all listed authors.

Duplicate or multiple publication

Submission of the manuscript means that the paper is original and has not yet been totally or partially published, is not currently under evaluation elsewhere, and, if accepted, will not be published elsewhere either wholly or in part.

Splitting the data concerning one study in more than one publication could be acceptable if authors justify the choice with good reasons both in the cover letter and in the manuscript. Authors should state what new scientific contribution is contained in their manuscript compared to any previously published article derived from the same study. Relevant previously published articles should be included in the cover letter of the currently submitted article.

Permissions to reproduce previously published material

Material (such as illustrations) taken from other publications must be accompanied by the publisher’s permission.

Copyright

The Authors agree to transfer the ownership of copyright to Panminerva Medica in the event the manuscript is published.

Ethics committee approval

All articles dealing with original human or animal data must include a statement on ethics approval at the beginning of the methods section, clearly indicating that the study has been approved by the ethics committee. This paragraph must contain the following information: the identification details of the ethics committee; the name of the chairperson of the ethics committee; the protocol number that was attributed by the ethics committee and the date of approval by the ethics committee.

The journal adheres to the principles set forth in the Helsinki Declaration (http://www.wma.net/en/30publications/10policies/b3/index.html) and states that all reported research concerning human beings should be conducted in accordance with such principles. The journal also adheres to the International Association of Veterinary Editors’ Consensus Author Guidelines on Animal Ethics and Welfare (http://www.veteditors.org/consensus-author-guidelines-on-animal-ethics-and-welfare-for-editors) and requires that all research on animals be conducted in accordance with these principles.

Patient consent

Authors should include at the beginning of the methods section of their manuscript a statement clearly indicating that patients have given their informed consent for participation in the research study.

Every precaution must be taken to protect the privacy of patients. Authors should obtain permission from the patients for the publication of photographs or other material that might identify them. If necessary a copy of such permission may be requested.

Conflicts of interest

Authors must disclose possible conflicts of interest including financial agreements or consultant relationships with organizations involved in the research. All conflicts of interest must be declared both in the authors’ statement form and in the manuscript file. If there is no conflict of interest, this should also be explicitly stated as none declared. All sources of funding should be acknowledged in the manuscript.

Authorship and contributorship

All persons and organizations that have participated to the study must be listed in the byline of the article (authors) or in the notes (contributors). The manuscript should be approved by all co-authors, if any, as well as, tacitly or explicitly, by the responsible authorities of the institution where the work was carried out. Authors and contributors must meet the criteria for authorship and contributorship established by the Uniform Requirements for Manuscripts Submitted to Biomedical Editors by the International Committee of Medical Journal Editors (http://www.icmje.org/recommendations/browse/roles-and-responsibilities/defining-the-role-of-authors-and-contributors.html).

Authors’ statement

Papers must be accompanied by the authors’ statement (http://www.minervamedica.it/en/journals/panminerva-medica/index.php) relative to copyright, originality, authorship, ethics and conflicts of interest, signed by all authors.

Disclaimer

The Publisher, Editors, and Editorial Board cannot be held responsible for the opinions and contents of publications contained in this journal.

The authors implicitly agree to their paper being peer-reviewed. All manuscripts will be reviewed by Editorial Board members who reserve the right to reject the manuscript without entering the review process in the case that the topic, the format or ethical aspects are inappropriate. Once accepted, all manuscripts are subjected to copy editing. If modifications to the manuscript are requested, the corresponding author should send to the online Editorial Office the revised manuscript under two separate files, one file containing the revised clean version and another containing both a letter with point-by-point responses to the reviewers’ comments and the revised version with corrections highlighted.

Correction of proofs should be limited to typographical errors. Substantial changes in content (changes of title and authorship, new results and corrected values, changes in figures and tables) are subject to editorial review. Changes that do not conform to the journal’s style are not accepted. Corrected proofs must be sent back within 3 working days to the online Editorial Office of Panminerva Medica. In case of delay, the editorial staff of the journal may correct the proofs on the basis of the original manuscript.

Publication of manuscripts is free of charge. Colour figures, linguistic revision, and excessive alterations to proofs will be charged to the authors. Authors will receive instructions on how to order reprints and a copy of the manuscript in PDF.

For further information about publication terms please contact the Editorial Office of Panminerva Medica, Edizioni Minerva Medica, Corso Bramante 83-85, 10126 Torino, Italy – Phone +39-011-678282 – Fax +39-011-674502

E-mail: journals6.dept@minervamedica.it.

ARTICLE TYPES

Instructions for the most frequent types of articles submitted to the journal.

Editorials. Commissioned by the Editor in Chief or the Managing Editor, editorials deal with a subject of topical interest about which the author expresses his/her personal opinion. No more than 1000 words (3 typed, double-spaced pages) and up to 15 references will be accepted.

Original articles. These should be original contributions to the subject. The text should be 3000-5500 words (8 to 16 typed, double-spaced pages) not including references, tables, figures. No more than 50 references will be accepted. The article must be subdivided into the following sections: introduction, materials (patients) and methods, results, discussion, conclusions. The introduction should describe the theoretical background, the aim of the study and the hypothesis to be tested. The materials and methods section should describe in a logical sequence how the study was designed and carried out, how the data were analyzed (what hypothesis was tested, what type of study was carried out, how randomization was done, how the subjects were recruited and chosen, provide accurate details of the main features of treatment, of the materials used, of drug dosages, of unusual equipments, of the statistical method ...). In the results section the answers to the questions posed in the introduction should be given. The results should be reported fully, clearly and concisely supported, if necessary, by figures, graphs and tables. The discussion section should sum up the main results, critically analyze the methods used, compare the results obtained with other published data and discuss the implica-tions of the results. The conclusions should briefly sum up the significance of the study and its future implications. For randomised controlled trials it is suggested to the authors to follow the guidelines reported by the CONSORT statement (http://www.consort-statement.org).

Review articles. These articles are commissioned by the Editor in Chief or the Managing Editor. They should discuss a topic of current interest, outline current knowledge of the subject, analyze different opinions regarding the problem discussed, be up-to-date on the latest data in the literature. Systematic reviews and meta-analyses must be subdivided into the following sections: introduction, evidence acquisition, evidence synthesis, conclusions. For systematic reviews and meta-analyses it is suggested to the authors to follow the guidelines reported by the PRISMA statement (http://www.prisma-statement.org). The text should be 6000-12000 words (17 to 34 typed, double-spaced pages) not including references, tables, figures. No more than 100 references will be accepted.

Case reports. These give a description of particularly interesting cases. The text should be 2000-3000 words (6 to 8 typed, double-spaced pages) not including references, tables, figures. No more than 30 references will be accepted. The article must be subdivided into the following sections: introduction, case report or clinical series, discussion, conclusions. It is suggested to the authors to follow the guidelines reported by the CARE statement (http://www.care-statement.org).

Special articles. These are articles on the history of medicine, health care delivery, ethics, economic policy and law concerning internal medicine. The text should be 3000-7000 words (8 to 20 typed, double-spaced pages) not including references, tables, figures. No more than 50 references will be accepted.

Letters to the Editor. These may refer to articles already published in the journal or to a subject of topical interest that the authors wish to present to readers in a concise form. The text should be 500-1000 words (1 to 3 typed, double-spaced pages) not including references, tables, figures. No more than 5 references will be accepted.

Guidelines. These are documents drawn up by special committees or authoritative sources.

The number of figures and tables should be appropriate for the type and length of the paper.

 

编辑委员会

总编辑:ML BENZO(意大利都灵)

总编辑:A. OLIARO(意大利都灵)

副主编:R.PELLICANO(意大利都灵)

编辑顾问委员会:L. ALLEGRA(意大利米兰) - BOGETTO(意大利都灵) - G. BONA(意大利诺瓦拉)

E. BRAUNWALD(美国波士顿) - D. CATTRAN(加拿大多伦多) - KR CHAPMAN(加拿大多伦多)

G. CORRAO(意大利米兰) - A. CRAXI (意大利巴勒莫) - G. DI PERRI(意大利都灵) - I. EARDLEY(英国利兹)

G. GASBARRINI(意大利罗马) - SJ MACHIN(英国伦敦) - JR MALAGELADA(西班牙巴塞罗那)

F. MALLAMACI(意大利雷焦卡拉布里亚) - G. MELIOLI(意大利热那亚) - P. MORTIMER(英国伦敦)

D. RUBELLO(意大利帕多瓦) - MB TAMBURRINO(托莱多,美国) - GB THOMPSONRochester,美国)

C. TYLER-SMITH(英国牛津) - F. VEITH(布朗克斯,美国) - CC ZIELINSKI(维也纳,奥地利)


投稿问答最小化  关闭